Cannabis Global (MCTC) Begins
Initial Distribution of Industry's First THC-V
Beverages
LOS ANGELES,
CA -- May 27, 2020 -- InvestorsHub NewsWire -- Cannabis Global,
Inc. (OTC: MCTC)
("Cannabis Global" or the "Company"), a cannabinoid and hemp
extract science-forward company developing infusion and delivery
technologies, is excited to announce it has completed product
development and has begun distribution of its unique
tetrahydrocannabivarin (THC-V) coffee and tea products
to product beta
testers.
Pending full release of the
products, the Company has implemented a 30-Day beta testing period,
during which production for general release will
continue.
Cannabis Global has integrated
three internally developed technologies into the unique
manufacturing process for the industry's first THC-V beverages. The
first of these is the process developed by the Company to produce
70%+ loaded THC-V, controlled release, nanoparticles utilizing
laboratory-based, pharmaceutical-grade production equipment. The
Company is also utilizing both its internally developed
powerization and one step dosing system, ensuring precise dosing
and significantly faster production. The Company has filed
provisional patents on all three technologies.
"Our unique infusion and
production technologies provide Cannabis Global with a product
purity advantage as well as a clear path to low cost
leadership," commented CEO Arman
Tabatabaei. "The THC-V cannabinoids are
synthesized and entirely free of impurities. While there were some
upfront technology development and intellectual property protection
costs, we expect our ongoing variable production costs to be less
than half of any potential competitor. Via our technologies, we
turn one of the cannabis industry's most expensive items
–
pure THC-V
cannabinoids – into a cost-effective solution
that sets a new standard for product purity in the
cannabinoid-based products marketplace."
The Company's first THC-V beverages are
three blends of super-premium coffee packaged in compostable,
single-serving coffee pods and several blends of organic green,
black and pu'er teas, all packaged in
single-serving formats.
Product and technology
developments were a result of the Company's Project Varin, which was
implemented last year to invent new manufacturing and infusion
technologies for rare cannabinoids, such as THC-V. The Company
plans to utilize the developed technologies in similar applications
for other rare cannabinoids, with cannabigerol (CBG) being the
likely next target for integration into the
Company's beverage products.
THC-V is not scheduled at the
federal level. The
Company's THC-V products contain zero
tetrahydrocannabinol (THC), far below the acceptable federal level
of 0.3%, and zero heavy metals, pesticide and herbicide residues,
nitrates and other impurities that are contained in most cannabis
and hemp products. The Company's products are not intended to
diagnose, treat, cure or prevent any disease and are not for use by
or sale to persons under the age of 18. The statements made
regarding these products have not been evaluated by the Food and
Drug Administration. The efficacy of these products has not been
confirmed by FDA-approved research. These products are not intended
to diagnose, treat, cure or prevent any disease. All information
presented here is not meant as a substitute for or alternative to
information from health care practitioners. Please consult your
health care professional about potential interactions or other
possible complications before using any product.
About
Cannabis Global, Inc.
Cannabis Global, Inc., formerly
known as MCTC Holdings, Inc., is a fully audited and reporting
Company with the U.S. Securities & Exchange Commission, trading
with the stock symbol MCTC. The Company is an emerging force in the
area of cannabinoid sciences and highly bioavailable hemp and
cannabis infusion technologies. The Company does not engage in the
production, distribution, or sales of any controlled substances,
including marijuana. The Company has an actively growing portfolio
of intellectual property having filed six patents in the areas of
cannabinoid delivery systems and cannabinoid polymeric
nanoparticles. The Company markets its consumer products under the
Hemp You Can Feel brand name. Cannabis Global launched is Project
Varin early in 2020, to develop new delivery methods for rare
cannabinoid Tetrahydrocannabivarin (THV-C) and to develop products
based on this cannabinoid.
Forward-looking
Statements
This news
release contains "forward-looking statements" which are not purely
historical and may include any statements regarding beliefs, plans,
expectations or intentions regarding the future. Such
forward-looking statements include, among other things, the
development, costs and results of new business opportunities and
words such as "anticipate", "seek", intend", "believe", "estimate",
"expect", "project", "plan", or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Actual results could
differ from those projected in any forward-looking statements due
to numerous factors. Such factors include, among others, the
inherent uncertainties associated with new projects, the future
U.S. and global economies, the impact of competition, and the
Company's reliance on existing regulations regarding the use and
development of cannabis-based products. These forward-looking
statements are made as of the date of this news release, and we
assume no obligation to update the forward-looking statements, or
to update the reasons why actual results could differ from those
projected in the forward-looking statements. Although we believe
that any beliefs, plans, expectations and intentions contained in
this press release are reasonable, there can be no assurance that
any such beliefs, plans, expectations or intentions will prove to
be accurate. Investors should consult all of the information set
forth herein and should also refer to the risk factors disclosure
outlined in our annual report on Form 10-k, our quarterly reports
on Form 10-Q and other periodic reports filed from time-to-time
with the Securities and Exchange Commission. For more information,
please visit www.sec.gov.
For more
information, please contact:
Arman
Tabatabaei,
IR@cannabisglobalinc.com
+1-(310)-986-4929
Cannabis Global (PK) (USOTC:CBGL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cannabis Global (PK) (USOTC:CBGL)
Historical Stock Chart
From Apr 2023 to Apr 2024
